Wendy Holman is the CEO of Ridgeback Biotherapeutics which develops potential medications to treat infectious diseases that have limited or no treatment options like Ebola and Covid-19. Recently she is being interviewed by CNBC News about their potential Covid Pill which they will be releasing with their partner Merck & Co.
Early Life
Wendy Holman must be aged in her 40s. She has not shared details about her exact birth date or place with the media yet. The details about her parents and siblings are also not in limelight. At a young age, she always wanted to do something so that she can alleviate human suffering easily. Wendy has completed her high school education but has not shared details about her high school. She later went to the University of Pennsylvania- The Wharton School. By looking at her career she must have done a course in the field of Biotechnology.
Wendy Holman Career
At schooling, she gained theoretical knowledge and after completing her education she began her career by applying that theoretical knowledge. In August 1999 she worked for Ziff Brothers Investments as Principal, Managing Director, and Director of Research. She worked with them for 14 years. In August 2017 she became a member of the Board of Trustees at Sabin Vaccine Institute. Next year she was seen as Trustee for Ransom Everglades School.
With so much experience she was later seen as CEO and Co-Founder of Ridgeback Biotherapeutics. Her company has received FDA approval in 2020 for the treatment of Ebola. The company is truly focused to serve everyday patients to fight diseases and deliver solutions. Recently they were partnered with Merck &Co. which is a U.S. drugmaker. The antiviral pills which they will be releasing have raised hopes of preventing Covid-19 deaths. The name of the drug is Molnupiravir which would also be the 1st oral antiviral covid-19 drug.
Wendy Holman Biography |
|
|---|---|
| Real Name | Wendy Commins Holman |
| Birth Date | 1980s |
| Age (as of 2021) | 40s |
| Birth Place | Miami Beach, Florida, United States |
| Nationality | American |
| Profession | CEO of Ridgeback Biotherapeutics |
| Religion | Christianity |
| Sun sign | Not Known |
Physical Statistics |
|
 |
|
| Height | in feet inches – 5’ 7” – in Centimeters – 170 cm |
| Weight | in Kilograms – 60 kg – in Pounds – 132 lbs |
| Shoe Size | 7 (U.S.) |
| Hair Color | Dark Brown |
| Eye Color | Dark Brown |
| Body Type | Slim |
Family |
|
| Father | – |
| Mother | – |
| Sister | – |
| Brother | – |
Qualification/Education |
|
| School | Wharton School of the University of Pennsylvania |
| College | Not Known |
Relationship Status |
|
| Marital Status | Married |
| Who is her husband? | Dr. Wayne Holman |
| Children? | None |
Personal Life
Wendy is married to Wayne. She and her husband have started a Biotherapeutics Company named Ridgeback. They tied their knot in a private wedding ceremony and have not shared details about the same. The couple is happily spending their life together, away from the limelight.
Wendy Holman Net Worth
Wendy Holman has earned a lot by working various jobs as an investor and also being the CEO of Ridgeback Biotherapeutics. It is estimated that her net worth is around $3 million dollars. She also earns by giving interviews and attending various events.
Trivia
- She is currently residing in Miami Beach, Florida, United States of America.
- In 2015 she was seen as a Member Board of Overseers at the University of Pennsylvania Libraries.
- In 2019 she was seen as a Member of the Presidential Advisory Council on HIV/AIDS.
- Wendy used to spend her time at Rosengarten or at Law School Library when she was studying at Penn University.
- She and her team are invested in developing coronavirus as well as other new pathogens treatments.
- She and her husband Wayne were seen on CNBC’s Squawk on the Street show.
